Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Ildikó, Garai"'
Autor:
Regina Esze, Sándor Barna, Péter Fülöp, Péter Kempler, Márton Mikó, Dénes Páll, György Paragh, Sándor Somodi, Miklós Emri, Zita Képes, Ildikó Garai, Miklós Káplár
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 16, Iss 1, Pp 1-11 (2024)
Abstract Background In order to investigate microvascular complications in metabolic diseases, we aimed to investigate cerebral and peripheral microcirculation in relation to peripheral neuropathy and laboratory biomarkers in type 2 diabetes mellitus
Externí odkaz:
https://doaj.org/article/3e94e9077aca4d6c902f74b94479cc17
Autor:
Csaba Csikos, Péter Czina, Szabolcs Molnár, Anna Rebeka Kovács, Ildikó Garai, Zoárd Tibor Krasznai
Publikováno v:
Diagnostics, Vol 14, Iss 16, p 1740 (2024)
The cornerstone of ovarian cancer treatment is complete surgical cytoreduction. The gold-standard option in the absence of extra-abdominal metastases and intra-abdominal inoperable circumstances is primary cytoreductive surgery (CRS). However, achiev
Externí odkaz:
https://doaj.org/article/e5bd05ff65eb43ba81602ea41263b92b
Autor:
Csaba Csikos, Adrienn Vágner, Gábor Nagy, Ibolya Kálmán-Szabó, Judit P. Szabó, Minh Toan Ngo, Zoltán Szoboszlai, Dezső Szikra, Zoárd Tibor Krasznai, György Trencsényi, Ildikó Garai
Publikováno v:
Diagnostics, Vol 13, Iss 2, p 236 (2023)
Among humanized monoclonal antibodies, bevacizumab specifically binds to vascular endothelial growth factor A (VEGF-A). VEGF-A is an overexpressed biomarker in cervix carcinoma and is involved in the development and maintenance of tumor-associated ne
Externí odkaz:
https://doaj.org/article/061d48f6b31f4c4cbe486fb6af77407b
Publikováno v:
Orvosi Hetilap. 164:403-410
Már a 2000-es évek elejétől jelentősen javult a Hodgkin-lymphomás betegek teljes és betegségmentes túlélése, köszönhetően az ABVD- (adriamicin, bleomicin, vinblasztin, dakarbazin) polikemoterápia elterjedésének és a modern sugárkez
Autor:
Dániel Szücs, Tibor Csupász, Judit P. Szabó, Adrienn Kis, Barbara Gyuricza, Viktória Arató, Viktória Forgács, Adrienn Vágner, Gábor Nagy, Ildikó Garai, Dezső Szikra, Imre Tóth, György Trencsényi, Gyula Tircsó, Anikó Fekete
Publikováno v:
Pharmaceuticals, Vol 15, Iss 6, p 666 (2022)
Hypoxia promotes angiogenesis, which is crucial for tumor growth, and induces malignant progression and increases the therapeutic resistance. Positron emission tomography (PET) enables the detection of the hypoxic regions in tumors using 2-nitroimida
Externí odkaz:
https://doaj.org/article/843f4628244a414b8a57736cdc4ebaed
Autor:
Bence Farkas, Zita Képes, Sándor Kristóf Barna, Viktória Szugyiczki, Magdolna Bakos, Attila Forgács, Ildikó Garai
Publikováno v:
Annals of Nuclear Medicine. 36:804-811
Purpose We aimed at examining both the incidence and extent of different lung perfusion abnormalities as well as the relationship between them on Tc-99m macroaggregated albumin (MAA) perfusion-only SPECT/CT scans in COVID-19 patients. Methods Ninety-
Autor:
Ibolya Kálmán-Szabó, Zita Képes, Anikó Fekete, Adrienn Vágner, Gábor Nagy, Dániel Szücs, Barbara Gyuricza, Viktória Arató, József Varga, Levente Kárpáti, Ildikó Garai, István Mándity, Frank Bruchertseifer, János Elek, Dezs Szikra, György Trencsényi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d67a627695007d93e0e178229477d9e
https://doi.org/10.2139/ssrn.4369312
https://doi.org/10.2139/ssrn.4369312
Autor:
Zita Képes, Márton Mikó, Kornél Kukuts, Regina Esze, Sándor Barna, Sándor Somodi, Miklós Káplár, József Varga, Ildikó Garai
Publikováno v:
Acta Radiologica. 64:187-194
Background Sensitive imaging modalities in the diagnosis of microcircular complications of the lower extremities induced by metabolic diseases are becoming a focus of interest. Purpose To investigate the [99mTc]HMPAO uptake of the legs in type 2 diab
Autor:
Trencsényi, Zita Képes, Alexandra Barkóczi, Judit P. Szabó, Ibolya Kálmán-Szabó, Viktória Arató, Ildikó Garai, Péter Árkosy, István Jószai, Ádám Deák, István Kertész, István Hajdu, György
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 21; Pages: 13060
Given the rising prevalence of lipid metabolic disorders and malignant diseases, we aimed to establish an in vivo hypercholesterinaemic tumour-bearing rat model for the induction and assessment of these conditions. A normal standard CRLT/N, 2 (baseli
Autor:
Zita, Képes, Alexandra, Barkóczi, Judit P, Szabó, Ibolya, Kálmán-Szabó, Viktória, Arató, Ildikó, Garai, Péter, Árkosy, István, Jószai, Ádám, Deák, István, Kertész, István, Hajdu, György, Trencsényi
Publikováno v:
International journal of molecular sciences. 23(21)
Given the rising prevalence of lipid metabolic disorders and malignant diseases, we aimed to establish an in vivo hypercholesterinaemic tumour-bearing rat model for the induction and assessment of these conditions. A normal standard CRLT/N, 2 (baseli